A - Human Necessities – 61 – L
Patent
A - Human Necessities
61
L
A61L 27/54 (2006.01) A61K 31/395 (2006.01) A61L 27/14 (2006.01) A61L 27/28 (2006.01)
Patent
CA 2512056
This invention relates to stents comprising an effective amount of a c-Jun N- terminal kinase (~JNK~) Inhibitor, the stents being useful for treating or preventing a cardiovascular or renal disease. The invention also relates to the treatment or prevention of cardiovascular or renal disease, such as atherosclerosis or restenosis, comprising implanting into a patient in need thereof of a stent comprising an effective amount of a JNK Inhibitor.
La présente invention concerne des stents comprenant une quantité suffisance d'un inhibiteur de JNK (c-Jun N-terminal kinase), ces stents convenant pour le traitement ou la prévention d'une affection cardio-vasculaire ou rénale. L'invention concerne également le traitement ou la prévention d'une affection cardio-vasculaire ou rénale, telle que l'athérosclérose ou la resténose, par implantation, chez un patient justifiant d'un tel traitement, d'un stent comportant une quantité suffisante d'un inhibiteur de JNK.
Celgene Corporation
Osler Hoskin & Harcourt Llp
LandOfFree
Drug-coated stents and methods of use therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug-coated stents and methods of use therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug-coated stents and methods of use therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1490579